FDA Inspection
Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. – FDA Inspection, Jun 11, 2014
Record Details
This FDA Inspection record concerns Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc., with an inspection on June 11, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- June 11, 2014
- Product Type
- Drugs
View Company Profile
ID · 70fa6721-6779-4ac9-855d-32a3aed7a3fe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 884329
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
11| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | VAI | New Orleans District Office | Drug Quality Assurance |
| April 12, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 14, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.